Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)

Clinical trial NCT00079482 · COMPLETED

Trial details

NCT number: NCT00079482
Sponsor: Cephalon
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2003-10-01
Primary completion: 2009-03-01
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.